← Open Payments lookup

CARRIE WEAVER: Open Payments

NPI 1851065825 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$785 in 37 payments from 13 companies in 2025. Trend: 2023 $111 · 2024 $100 · 2025 $785

Food & beverage: $785
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.5$114
Supernus Pharmaceuticals, Inc.3$78
Alkermes, Inc.3$74
Otsuka America Pharmaceutical, Inc.3$71
Takeda Pharmaceuticals U.S.A., Inc.4$69
Axsome Therapeutics, Inc.4$67
Collegium Pharmaceutical, Inc.3$64
Lundbeck LLC3$62
Noven Therapeutics, LLC3$61
ABBVIE INC.2$39

Products named: REXULTI, Qelbree, ARISTADA, HETLIOZ, TRINTELLIX, Auvelity, Jornay PM, Xelstrym.

Industry payments across NE — which companies pay providers there.